Cutera, Inc. (NASDAQ:CUTR) Short Interest Update

Cutera, Inc. (NASDAQ:CUTR) saw a significant decline in short interest in the month of December. As of December 15th, there was short interest totalling 4,080,000 shares, a decline of 7.3% from the November 30th total of 4,400,000 shares. Based on an average daily trading volume, of 292,300 shares, the days-to-cover ratio is currently 14.0 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Cutera in a research report on Saturday. They set a “sell” rating for the company.

Hedge Funds Weigh In On Cutera

A number of hedge funds and other institutional investors have recently made changes to their positions in CUTR. Ground Swell Capital LLC purchased a new position in Cutera during the 2nd quarter valued at $37,000. Squarepoint Ops LLC increased its position in shares of Cutera by 164.5% during the second quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock valued at $172,000 after buying an additional 70,870 shares during the period. Finally, Bank of Montreal Can raised its stake in Cutera by 14.2% in the second quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after buying an additional 35,248 shares in the last quarter. Institutional investors own 90.70% of the company’s stock.

Cutera Price Performance

CUTR opened at $0.33 on Monday. The firm has a market capitalization of $6.62 million, a price-to-earnings ratio of -0.05 and a beta of 1.26. Cutera has a one year low of $0.28 and a one year high of $4.97. The business has a 50 day simple moving average of $0.44 and a two-hundred day simple moving average of $0.84.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.